Shawver Laura Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
22
Insider Sells Sum
$8.63M

Insider Activity of Shawver Laura

Biography of Shawver Laura

No biography is available at this moment.

2025-04-07SaleARS Pharmaceuticals, Inc.
SPRY
director
50,002
0.0489%
$12.30$615,075-15.9%
2025-03-06SaleARS Pharmaceuticals, Inc.
SPRY
director
49,600
0.0524%
$11.21$556,046+6.49%
2025-03-05SaleARS Pharmaceuticals, Inc.
SPRY
director
400
0.0004%
$11.00$4,400+5.7%
2025-02-03SaleARS Pharmaceuticals, Inc.
SPRY
director
50,000
0.0486%
$12.31$615,565-4.39%
2025-01-06SaleARS Pharmaceuticals, Inc.
SPRY
director
50,000
0.0511%
$11.10$555,065+10.6%
2024-12-04SaleARS Pharmaceuticals, Inc.
SPRY
director
14,772
0.0146%
$13.75$203,109-13.28%
2024-12-03SaleARS Pharmaceuticals, Inc.
SPRY
director
87,984
0.0888%
$13.26$1.17M-7.97%
2024-12-02SaleARS Pharmaceuticals, Inc.
SPRY
director
97,244
0.1019%
$13.56$1.32M-5.78%
2023-09-01SaleARS Pharmaceuticals, Inc.
SPRY
director
100,000
0.0546%
$7.71$770,520+15.19%
2023-08-04SaleARS Pharmaceuticals, Inc.
SPRY
director
18,897
0.0095%
$7.06$133,471+3.27%
2023-08-03SaleARS Pharmaceuticals, Inc.
SPRY
director
26,107
0.013%
$7.01$183,018+3.71%
2023-08-02SaleARS Pharmaceuticals, Inc.
SPRY
director
36,281
0.0182%
$7.09$257,265+2.49%
2023-08-01SaleARS Pharmaceuticals, Inc.
SPRY
director
18,715
0.0095%
$7.19$134,576-0.7%
2023-07-07SaleARS Pharmaceuticals, Inc.
SPRY
director
8,858
0.004%
$6.36$56,372+14.76%
2023-07-06SaleARS Pharmaceuticals, Inc.
SPRY
director
33,510
0.0151%
$6.34$212,554+9.33%
2023-07-05SaleARS Pharmaceuticals, Inc.
SPRY
director
31,112
0.0142%
$6.41$199,552+8.32%
2023-07-03SaleARS Pharmaceuticals, Inc.
SPRY
director
26,520
0.0126%
$6.72$178,347+4.31%
2023-06-02SaleARS Pharmaceuticals, Inc.
SPRY
director
26,941
0.0133%
$6.95$187,240-6.35%
2023-06-01SaleARS Pharmaceuticals, Inc.
SPRY
director
73,059
0.0352%
$6.80$496,801-1.16%
2023-05-09SaleARS Pharmaceuticals, Inc.
SPRY
director
42,900
0.0162%
$5.31$227,799+31.07%
Total: 22
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.